Literature DB >> 4606891

Pathophysiologic effects of lethal and immunoregulatory doses of cholera enterotoxin in the mouse.

F V Chisari, R S Northrup.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4606891

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  10 in total

1.  Differential effect of cholera toxin on CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation of human naive T cells.

Authors:  K Eriksson; I Nordström; C Czerkinsky; J Holmgren
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Suppression of the immune response by microorganisms.

Authors:  J H Schwab
Journal:  Bacteriol Rev       Date:  1975-06

3.  Lymphopenia and impaired immunological activities of splenocytes during the immune response to cholera enterotoxin.

Authors:  J R Kateley; J Holderbach; H Friedman
Journal:  Immunology       Date:  1978-10       Impact factor: 7.397

4.  In vitro inhibition of human peripheral blood lymphocyte transformation by an extract of Pseudomonas putida.

Authors:  C V Hunt; W Khan; G Friedman; J C Houck
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

5.  Studies on the genetic and cellular control of sensitivity to enterotoxins in the sealed adult mouse model.

Authors:  S H Richardson; R E Kuhn
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

6.  Intercellular immunological controls and modulation of cyclic AMP levels. Some doubts.

Authors:  M C Berenbaum; E C Purves; I E Addison
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

7.  Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.

Authors:  S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Sealed adult mice: new model for enterotoxin evaluation.

Authors:  S H Richardson; J C Giles; K S Kruger
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

9.  Preclinical pharmacology of cholera toxin.

Authors:  J M Reid; J W Benson; J Viallet; M M Ames
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

10.  Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.

Authors:  R Weltzin; B Guy; W D Thomas; P J Giannasca; T P Monath
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.